InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Craig Adam R, Chairman & CEO. Insider active across 1 companies, notably CTI Biopharma CORP. Cumulatively, 4 disclosures have been logged. The latest transaction was disclosed on 1 June 2022 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations4 total
€21,31527,000 shares@ €0.789547.2% of flow
common stock
SEC:0000891293-22-000027:0·
€5,9153,178 shares@ €1.861413.1% of flow
Common Stock
SEC:0000899243-22-010768:0·
€8,9615,000 shares@ €1.7922100.0% of flow
common stock
SEC:0000891293-21-000045·
€8,9615,000 shares@ €1.792219.8% of flow
common stock
SEC:0000891293-21-000045:0·
4 of 4 declarations
About Craig Adam R
Craig Adam R is the President and CEO of CTI Biopharma Corp. He leads the company in developing innovative treatments for blood diseases. His role is crucial in guiding the research and development strategy and ensuring regulatory compliance.
